COVID-19 Daily - November 15: UK approves booster dose for people over 40; the infection rate in Germany has reached its highest level.
While some states boast record vaccinations, others boast records of new coronavirus cases. Germany, Russia, Austria, among the states affected by the new wave of COVID-19. Let's see the news about the pandemic:
- Austria authorized the first lockdown at national level for unvaccinated persons over 12 years of age. The measure is being taken to stop the alarming increase in the number of new cases of coronavirus and the increasing pressure on intensive care units. Austria is the first country in the world to take this drastic measure. The unvaccinated quarantine takes effect at midnight.
- The United Kingdom has approved the administration of the booster dose for people over the age of 40. Currently, anyone over the age of 50, along with vulnerable health care workers and front-line workers, is eligible for the booster dose.
Russia has reported what is close to the all-time high for new deaths and cases.
- Russia has reported what is close to the all-time high for new deaths and cases. The death toll has reached 1.211 in the last 24 hours. The figures come a week after most of Russia lifted the five-day lockdown at work, aimed at reducing the increase in the number of cases.
- Italy is investigating anti-vaccine networks for inciting violence on online groups. Searches were carried out in 16 cities in the country and targeted 17 of the most radical participants on the Telegram group "Jos Dictatura", which has tens of thousands of followers and is "characterized by permanent incitement to hatred and encouragement of serious crimes."
- The world's second largest cinema operator, Cineworld, says its sales reached 90% of pre-COVID levels in October 2021. This led to a 14% increase in the shares of the London-listed company. Returning to theaters has been helped by high-budget movies, including Marvel's Black Widow, Shang-Chi and the Legend of the Ten Rings.
- Bahrain has become the first country in the world to approve the emergency use of AstraZeneca's Evusheld. It will be limited to people with occupations that put them at risk for transmission, as well as to adults who suffer from immunodeficiency or who take immunosuppressants.